Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides
Antimicrobial sulfonamides are important medications. However, their use is associated with major immune-mediated drug hypersensitivity reactions with a rate that ranges from 3% to 4% in the general population. The pathophysiology of sulfa-induced drug hypersensitivity reactions is not well understo...
Saved in:
Published in | Journal of clinical pharmacology Vol. 60; no. 3; p. 409 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.03.2020
|
Subjects | |
Online Access | Get more information |
ISSN | 1552-4604 |
DOI | 10.1002/jcph.1535 |
Cover
Loading…
Abstract | Antimicrobial sulfonamides are important medications. However, their use is associated with major immune-mediated drug hypersensitivity reactions with a rate that ranges from 3% to 4% in the general population. The pathophysiology of sulfa-induced drug hypersensitivity reactions is not well understood, but accumulation of reactive metabolites (sulfamethoxazole [SMX] hydroxylamine [SMX-HA] and SMX N-nitrosamine [SMX-NO]) is thought to be a major factor. These reactive metabolites contribute to the formation of reactive oxygen species (ROS) known to cause cellular damage and induce cell death through apoptosis and necroptosis. ROS can also serve as "danger signals," priming immune cells to mount an immunological reaction. We recruited 26 sulfa-hypersensitive (HS) patients, 19 healthy control subjects, and 6 sulfa-tolerant patients to this study. Peripheral blood monocytes and platelets were isolated from blood samples and analyzed for in vitro cytotoxicity, ROS and carbonyl protein formation, lipid peroxidation, and GSH (glutathione) content after challenge with SMX-HA. When challenged with SMX-HA, cells isolated from sulfa-HS patients exhibited significantly (P ≤ .05) higher cell death, ROS and carbonyl protein formation, and lipid peroxidation. In addition, there was a high correlation between cell death in PBMCs and ROS levels. There was also depletion of GSH and lower GSH/GSSG ratios in peripheral blood mononuclear cells from sulfa-HS patients. The amount of ROS formed was negatively correlated with intracellular GSH content. The data demonstrate a major role for oxidative stress in in vitro cytotoxicity of SMX reactive metabolites and indicate increased vulnerability of cells from sulfa-HS patients to the in vitro challenge. |
---|---|
AbstractList | Antimicrobial sulfonamides are important medications. However, their use is associated with major immune-mediated drug hypersensitivity reactions with a rate that ranges from 3% to 4% in the general population. The pathophysiology of sulfa-induced drug hypersensitivity reactions is not well understood, but accumulation of reactive metabolites (sulfamethoxazole [SMX] hydroxylamine [SMX-HA] and SMX N-nitrosamine [SMX-NO]) is thought to be a major factor. These reactive metabolites contribute to the formation of reactive oxygen species (ROS) known to cause cellular damage and induce cell death through apoptosis and necroptosis. ROS can also serve as "danger signals," priming immune cells to mount an immunological reaction. We recruited 26 sulfa-hypersensitive (HS) patients, 19 healthy control subjects, and 6 sulfa-tolerant patients to this study. Peripheral blood monocytes and platelets were isolated from blood samples and analyzed for in vitro cytotoxicity, ROS and carbonyl protein formation, lipid peroxidation, and GSH (glutathione) content after challenge with SMX-HA. When challenged with SMX-HA, cells isolated from sulfa-HS patients exhibited significantly (P ≤ .05) higher cell death, ROS and carbonyl protein formation, and lipid peroxidation. In addition, there was a high correlation between cell death in PBMCs and ROS levels. There was also depletion of GSH and lower GSH/GSSG ratios in peripheral blood mononuclear cells from sulfa-HS patients. The amount of ROS formed was negatively correlated with intracellular GSH content. The data demonstrate a major role for oxidative stress in in vitro cytotoxicity of SMX reactive metabolites and indicate increased vulnerability of cells from sulfa-HS patients to the in vitro challenge. |
Author | Rieder, Michael J Loubani, Eman Abuzgaia, Awatif M Bend, John R Sultan, Elham A Elzagallaai, Abdelbaset A |
Author_xml | – sequence: 1 givenname: Abdelbaset A surname: Elzagallaai fullname: Elzagallaai, Abdelbaset A organization: Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada – sequence: 2 givenname: Elham A surname: Sultan fullname: Sultan, Elham A organization: Department of Paediatrics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada – sequence: 3 givenname: John R surname: Bend fullname: Bend, John R organization: Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada – sequence: 4 givenname: Awatif M surname: Abuzgaia fullname: Abuzgaia, Awatif M organization: Department of Paediatrics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada – sequence: 5 givenname: Eman surname: Loubani fullname: Loubani, Eman organization: Department of Paediatrics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada – sequence: 6 givenname: Michael J surname: Rieder fullname: Rieder, Michael J organization: Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31709574$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tKAzEUQIMo9qELf0DyA1PzuplmKcW2QqHQ6rrkiSkzyTCZivP3CurqLA4cODN0nXLyCD1QsqCEsKez7T4WFDhcoSkFYJWQREzQrJQzIVQKoLdowmlNFNRiitaH3HicA95_RaeH-Onxceh9KTgmvB073xefSvwRcRjxwWs7xJwKHjI-XpqQk26j8-UO3QTdFH__xzl6X7-8rbbVbr95XT3vKiu4hCpQW2unnOZScWqIBZBCOa_pUhrtRE3BgtCCeRGI04ovgSkXQDpjjTbA5ujxt9tdTOvdqetjq_vx9D_EvgGje01C |
CitedBy_id | crossref_primary_10_1016_j_fct_2022_113471 crossref_primary_10_1007_s12016_023_08978_w crossref_primary_10_1007_s11356_021_17197_9 crossref_primary_10_1016_j_jaci_2020_01_030 crossref_primary_10_1080_17512433_2023_2289543 crossref_primary_10_1111_all_15126 crossref_primary_10_18036_estubtdc_1236273 crossref_primary_10_1016_j_chemosphere_2020_128350 crossref_primary_10_1111_all_15255 crossref_primary_10_3390_antiox10020294 crossref_primary_10_1007_s11030_024_10833_9 crossref_primary_10_1093_toxsci_kfae046 crossref_primary_10_1142_S1793984421410063 crossref_primary_10_1016_j_cej_2023_147094 crossref_primary_10_3390_foods10081897 crossref_primary_10_1016_j_ijbiomac_2023_128294 crossref_primary_10_3389_fimmu_2021_653102 crossref_primary_10_1007_s40291_023_00644_3 crossref_primary_10_1016_j_ecoenv_2022_113331 crossref_primary_10_2147_DHPS_S347522 crossref_primary_10_1038_s41565_022_01071_x crossref_primary_10_1007_s12016_021_08872_3 |
ContentType | Journal Article |
Copyright | 2019, The American College of Clinical Pharmacology. |
Copyright_xml | – notice: 2019, The American College of Clinical Pharmacology. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1002/jcph.1535 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1552-4604 |
ExternalDocumentID | 31709574 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- .55 .GJ 05W 0R~ 123 18M 1CY 1OB 1OC 29K 33P 34G 39C 3O- 3SF 4.4 52U 52V 53G 5RE 8-1 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCUV ABJNI ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADMGS ADNMO ADOZA ADSTG ADXAS AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFRAH AFWVQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AI. AIACR AIAGR AIDQK AIDYY AITYG AIURR ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AUVAJ AVWKF AZFZN AZVAB BDRZF BFHJK BHBCM BMXJE BOGZA BRXPI C45 CAG CGR COF CS3 CUY CVF D-I DCZOG DPXWK DRFUL DRMAN DRSTM DU5 EBD EBS ECM EIF EJD EMOBN F5P FEDTE FUBAC G-S GODZA GWYGA H13 HF~ HGLYW HVGLF IAO IEA IHR INH INR IVC KBYEO LATKE LEEKS LH4 LOXES LSO LUTES LW6 LYRES MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NPM O66 O9- OVD P2P P2W PALCI PQQKQ R.K RIWAO RJQFR ROL SAMSI SUPJJ SV3 TEORI VH1 WBKPD WH7 WIH WIJ WIK WOHZO WOIKV WPGGZ WXSBR X7M ZGI ZXP ZZTAW |
ID | FETCH-LOGICAL-c4365-f1c7ad9da36931b0c55649dea186bad4715c54a42e4f0da938529df56dbcbab52 |
IngestDate | Mon Jul 21 06:02:44 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | in vitro diagnosis sulfamethoxazole hydroxylamine adverse drug reactions drug allergy sulfamethoxazole idiosyncratic drug reactions |
Language | English |
License | 2019, The American College of Clinical Pharmacology. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4365-f1c7ad9da36931b0c55649dea186bad4715c54a42e4f0da938529df56dbcbab52 |
PMID | 31709574 |
ParticipantIDs | pubmed_primary_31709574 |
PublicationCentury | 2000 |
PublicationDate | 2020-March |
PublicationDateYYYYMMDD | 2020-03-01 |
PublicationDate_xml | – month: 03 year: 2020 text: 2020-March |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of clinical pharmacology |
PublicationTitleAlternate | J Clin Pharmacol |
PublicationYear | 2020 |
SSID | ssj0016451 |
Score | 2.4209616 |
Snippet | Antimicrobial sulfonamides are important medications. However, their use is associated with major immune-mediated drug hypersensitivity reactions with a rate... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 409 |
SubjectTerms | Adolescent Adult Aged Anti-Infective Agents - adverse effects Anti-Infective Agents - blood Anti-Infective Agents - metabolism Blood Platelets - metabolism Cell Survival - drug effects Child Drug Hypersensitivity - blood Drug Hypersensitivity - etiology Drug Tolerance Female Glutathione - metabolism Healthy Volunteers Humans Leukocytes, Mononuclear - metabolism Lipid Peroxidation - drug effects Lymphocytes - metabolism Male Middle Aged Oxidative Stress - drug effects Patients Protein Carbonylation - drug effects Reactive Oxygen Species - metabolism Sulfamethoxazole - adverse effects Sulfamethoxazole - analogs & derivatives Sulfonamides - adverse effects Sulfonamides - blood Sulfonamides - metabolism Young Adult |
Title | Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31709574 |
Volume | 60 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEF4FKlVcEG0p72oPKKc4tb0P4mOEglCltggSKTe0zxIUkgiMgPx6Zr1rxwoUtVwsy-v3Nx7PzM58g9Ch4dwSTnnEjyw4KITRSAolopSYVIiM6Vi54uSfv_jpgP4YsmGjMa9Xl-Syreav1pW8B1XYBri6Ktn_QLY6KWyAdcAXloAwLP8J4_OQGvj7caQ9gfeFL_1wBFbgYN7eufT00B_i3PgahoLS4eJ-bKeuF70OOYQv7dOqZnK2YLeu4u-98Vy4OXvhu1l3pSPLgh9ivoiNwiVyH13tja_ETS1oGoLZRdJONdHUlffzP8Kn7nYf4GlsCNSGkAT4n1VOVtsENcrSiHLfWLjUs75vQJAnUlOatCBIeKnMPTnstZpdtUEvs_o-gMPspkAV7B-wEn2nn7dHl3i1y6EVtAIehmuZ6uI8Yf6JU5aUPFRx-r26hzX0sTxuyQ8p7JH-BloPQOGul4pPqGEmn1HzzGP11ML9RWHdXQs38VkNxS_oxIkOnlpciQ72ooNHE7wsOrgSHZxPcV10NtHgpNc_Po1CS41IUZfPaBN1JHSmBeEZSWSsGOM000YkHS6FBkuFKUYFTQ21sRYZ6bA005ZxLZUUkqVf0epkOjHbCBvCYikz2YHvmdrMnYBqk3SoVkQyleygLf9-LmeeN-WyfHO7fx3ZQ2sLedpHHyx8qOYArL5cfisAegZrIlv5 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+Oxidative+Stress+in+Hypersensitivity+Reactions+to+Sulfonamides&rft.jtitle=Journal+of+clinical+pharmacology&rft.au=Elzagallaai%2C+Abdelbaset+A&rft.au=Sultan%2C+Elham+A&rft.au=Bend%2C+John+R&rft.au=Abuzgaia%2C+Awatif+M&rft.date=2020-03-01&rft.eissn=1552-4604&rft.volume=60&rft.issue=3&rft.spage=409&rft_id=info:doi/10.1002%2Fjcph.1535&rft_id=info%3Apmid%2F31709574&rft_id=info%3Apmid%2F31709574&rft.externalDocID=31709574 |